Introduction
Gli3 is a zinc finger transcription factor expressed in developing neural and non-neural tissues. It is an important component of the Sonic hedgehog (Shh) signalling pathway and Gli3 protein is cleaved into a short repressor form (Gli3R) in the absence of Shh (Blaess et al., 2006; Meyer and Roelink, 2003) . Levels of Gli3R are higher in dorsal structures most distant from the ventral Shh producing regions (Fotaki et al., 2006) . It has been suggested that Gli3R plays an active role in specifying dorsal telencephalic tissues (Rash and Grove, 2007) , but how it plays such a role remains unclear.
Evidence that Gli3 has important functions in embryogenesis has come from mutant mice lacking Gli3 function. Complete loss of Gli3 causes embryos to die around birth with severe defects at multiple sites including the limbs, which develop with extra digits, and the brain (Hui and Joyner, 1993; Johnson, 1967; Maynard et al., 2002; Theil, 2005; Vortkamp et al., 1992; Winter and Huson, 1988) . In the brain of Gli3 −/− embryos the most obvious defects are in the telencephalon which is severely diminished in size and often exhibits exencephaly (Copp, 1994) . Gli3 −/− brains that are not exencephalic fail to develop dorsomedial telencephalic structures including the hippocampus and cortical hem (Grove et al., 1998; Rash and Grove, 2007; Tole et al., 2000) . In the telencephalon, only a small remnant of dorsal telencephalic tissue persists between diencephalon and ventral telencephalon. This residual neocortex contains groups of cells that express diencephalic markers surrounded by dorsal telencephalic cells (Fotaki et al., 2006) . The explanation for the findings in Gli3 −/− embryos is likely to be complex. It is known that loss of Gli3 results in changes in the expression of key signalling molecules arising from signalling centres around the midline that would normally affect the development of the dorsal telencephalon. In the Gli3 −/− mutant forebrain, Fgf8 expression is expanded rostrally (Aoto et al., 2002; Theil et al., 1999) while Wnt expression in the dorsomedial telencephalon is greatly reduced (Grove et al., 1998; Kuschel et al., 2003; Tole et al., 2000) . It is likely that these changes in the production of signalling molecules affect the development of dorsal telencephalic structures, but they might not provide a full explanation. It is also possible that loss of Gli3 renders dorsal telencephalic cells intrinsically incompetent to generate and/or Developmental Biology 327 (2009) 
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Developmental Biology j o u r n a l h o m e p a g e : w w w. e l s e v i e r. c o m / d e v e l o p m e n t a l b i o l o g y maintain certain dorsal telencephalic tissues, either by preventing dorsal telencephalic cells proliferating and/or surviving in these regions or by causing them to adopt inappropriate fates. Testing this possibility requires approaches additional to the analysis of Gli3 −/− embryos, in which the phenotype is a net result of both cell nonautonomous and cell autonomous defects. Here, we studied the development of Gli3 −/− cells in the forebrain of chimeric embryos containing a majority of wild type cells (designated Gli3 +/+ ↔ Gli3 −/− or Gli3 −/− chimeras). The principle of this approach is that defects retained by Gli3 −/− cells are likely to be cell autonomous.
We studied chimeras in which proportions wild-type cells were relatively high, so as to optimize their ability to generate forebrain tissues regardless of the presence of mutant cells in their midst. We found that, despite the presence of mutant cells, wild-type cells did create dorsal telencephalic structures that are missing in Gli3
embryos. This allowed us to ask about the contributions and gene expression patterns of mutant cells embedded in an environment of wild-type cells in the process of creating all of the main forebrain structures. Our results indicate that Gli3 −/− cells do contribute to these structures but that do not attain their normal identities: many Gli3
−/− cells in dorsal telencephalon attain characteristics of either ventral telencephalon or diencephalon, depending on their location.
Materials and methods

Derivation of Gli3 −/− embryonic stem (ES) cells
We used mice carrying the Xt J null allele, a large deletion encompassing much of the Gli3 gene (Vortkamp et al., 1992) . Gli3
or Gli3 −/− ES cells (129Sv background) were derived from embryos obtained from Gli3 +/− female mice that were superovulated and mated with male Gli3 +/− mice that were in some cases homozygous for a reiterated β-globin repeat transgene ([TgN(Hbb-bl) 83Clo] -abbreviated to Tg hereafter) (Lo et al., 1987) . ES cells were derived from individually cultured blastocysts (Turksen, 2002) . The resulting ES cell lines were then passaged in feeder-free conditions in BHK-21 Glasgow MEM (GMEM; Invitrogen) with 15% fetal bovine serum (FBS) and LIF (1000 U/ml). Cell lines were genotyped for the Xt J allele and the Tg transgene and their glucose phosphate isomerase (GPI) isotypes were determined, as described previously (Quinn et al., 2007; Zaki et al., 2006) . All ES cell lines generated were karyotyped and those used for chimera generation had a normal chromosome complement.
Labelling ES cells by in vitro transfection
Subconfluent Gli3 +/+ or Gli3 −/− ES cells were dissociated using
Tryple Express™ (Invitrogen, UK) and plated in GMEM medium containing LIF and 15% FCS. Twenty four hours later, Fugene (Invitrogen, UK) was used to transfect cells with a plasmid (pEGFPN1; Clontech, UK) that expresses enhanced green fluorescent protein (EGFP) in all cells. Transfected cells were selected in medium containing 600 μg/μl G418. After 7 days in selection medium individual colonies were picked and expanded by passage in GMEM+FBS with LIF (1000 U/ml). Stably transfected EGFP expressing lines were used for blastocyst injections. Zaki et al. (2006) . In the case of chimeras made by methods (1) and (3) tissue was taken from the trunk of the embryo for genotyping while for chimeras produced by method (2) the yolk sac endoderm (which is not colonized by ES cells: Tam and Rossant, 2003) was dissected away from other extra-embryonic tissues and used for determining the genotype of the original host blastocysts (West and Flockhart, 1994) . The trunk of each embryo was used to obtain a measure of the global contribution of ES cell-derived embryonic tissue using GPI electrophoresis as described previously (Quinn et al., 2007) . ES cell lines were always GPI1A and donor blastocysts GPI1B. Embryos were fixed in 4% paraformaldehyde, wax-embedded and sections were cut (10 μm).
Chimera production and analysis
Experimental
Where the Tg marker was included, it was revealed by DNA-DNA in situ hybridisation (Lo et al., 1987; Quinn et al., 2007) . Counts of Tgpositive and Tg-negative cells were obtained using StereoInvestigator™ (MBF Bioscience, USA). The programme randomly assigned 150 × 150 μm counting boxes within each of a series of normal or abnormal forebrain tissues delineated as described in Results.
Immunohistochemistry
Antibodies to the following were used on wax-embedded sections using conventional methods: FoxG1 (1:100; Abcam, UK), calretinin (1:400; Swant Antibodies, Switzerland), reelin (1:100; Chemicon, UK), Nkx2.2 (1:100; Developmental Studies Hybridoma Bank [DSHB], USA), Pax6 (1:100; DSHB, USA), Mash1 (1:100; BD Biosciences, UK), Tbr2 (1:200; gift from R. Hevner, University of Washington, Seattle, USA), phosphohistone-3 (pH3; 1:400; Sigma, UK), Lim1/2 (1:200; DSHB, USA), Gsh2 (1:2500; gift from K. Campbell, Children's Hospital Research Foundation, Cincinnati, USA), MAP2 (1:100; Sigma, UK), Gad67 (1:100; Chemicon, UK), Nkx2.1 (1:100; Developmental Studies Hybridoma Bank [DSHB], USA), and Dlx2 (Abcam, UK, 1:100). Visualisation was achieved using anti-mouse or anti-rabbit biotin-conjugated secondary antibodies, amplified (ABC kit, Vector Laboratories, UK) and visualised by staining with diaminobenzidine (DAB) (Invitrogen, UK). In situ hybridisation for the presence of the β-globin transgene in conjunction with immunohistochemistry was performed as described previously (Quinn et al., 2007) , and was possible for many of the antibodies (see Results). In some cases where we were unable to get antibodies to stain on the same section as used for in situ hybridisation, we compared adjacent sections reacted immunohistochemically and with in situ hybridisation to identify clusters of Gli3 −/− cells (see Results).
Results
Chimera production
In total, 12 Gli3 +/+ ↔ Gli3 −/− chimeras and 15 Gli3 +/+ ↔ Gli3 +/+ chimeras were generated at embryonic days (E) 11.0, 12. The most obvious defect of non-chimeric Gli3 −/− telencephalon is failure of dorsal midline invagination and absence of dorsomedial telencephalic structures including the hippocampus and cortical hem (Grove et al., 1998; Theil et al., 1999; Tole et al., 2000) . In Gli3 +/+ ↔ Gli3 −/− chimeras dorsal midline invagination and structures resembling hippocampus and cortical hem were observed (Figs. 1A-F) . In all Gli3 +/+ ↔ Gli3 −/− chimeras, ventral telencephalon and diencephalon appeared relatively normal but dorsal structures contained numerous abnormalities (Fig. 1) . These abnormalities were consistent between Gli3 +/+ ↔ Gli3 −/− chimeras. Some parts of the neocortex were thicker than normal and there were large clusters of cells (marked with asterisks in Fig. 1B) , some of which contained a central lumen.
These clusters distorted the shape of the neocortex, including those regions with normal thickness and appearance (e.g. in the right hemisphere in Fig. 1B Fig. 1F ). In addition, ectopic tissue was seen bilaterally between the cortical hem and the choroid plexus (indicated as # in Fig. 1B) . ), indicating that there was an increased proportion of dividing cells in the Gli3 −/− clusters.
We determined the proportions of (i) Tg-negative Gli3 −/− cells in Gli3 +/+ ↔ Gli3 −/− E14.5 experimental chimeras and (ii) Tg-negative Gli3 +/+ cells in Gli3 +/+ ↔ Gli3 +/+ E14.5 control chimeras in a series of regions through the forebrain. We examined the contribution of these cells to each major diencephalic or telencephalic region. Results were highly consistent between chimeras of similar genotype: results from four chimeras are shown in Fig. 2 . The following regions in control chimeras and their clear equivalents in experimental chimeras were analysed: (i) dorsal thalamus (DT), (ii) eminentia thalami (ET), (iii) hippocampus (H), (iv) neocortex (Nctx), (v) lateral ganglionic eminence (LGE), (vi) medial ganglionic eminence (MGE) and (vii) caudal ganglionic eminence (CGE). The following additional tissues were analysed in In control chimeras ( Fig. 2A) , the contributions of Tg-negative cells in each region were very close to the contributions predicted by GPI analysis (red lines in Fig. 2A ). In experimental chimeras (Fig. 2B) , extremely high percentages of Gli3 −/− cells (∼80-100%) were found in structures with no clear counterparts in control chimeras (designated #, med⁎, lat⁎, nctx⁎). In some cases, these abnormal structures contained pockets of Gli3 +/+ cells that were highly segregated from the Gli3 −/− cells: this segregation underlies the large variation in the percentages recorded in different sampling boxes from the neocortical clusters in experimental chimera 2 (Fig. 2B, nctx⁎) , since some boxes contained all mutant cells while a few contained mainly wild type cells. There were also large variations in counts from many of the regions of experimental chimeras that were recognizably the Gli3 −/− cells in the Gli3 −/− ↔ Gli3 +/+ chimeric telencephalon exhibit altered identity in a location-specific manner A possible reason for segregation of mutant cells is a fundamental alteration in their identity. We tested this possibility using a range of markers expressed selectively in specific regions of the forebrain.
Foxg1 expression
In normal embryos, the forkhead transcription factor Foxg1 is expressed throughout the telencephalon but not the diencephalon (Tao and Lai, 1992; Xuan et al., 1995) . In Gli3 −/− ↔ Gli3 +/+ chimeras (E14.5, n = 3), Foxg1 expression was absent from both Gli3 −/− and Gli3 +/+ cells in diencephalon (Figs. 4A ,B,J) and was present in both Gli3 −/− and Gli3 +/+ cells throughout much of the telencephalon, with the exception of Gli3 −/− cells located dorsomedially (Figs. 4A-I ). At caudal levels (Fig. 4A) , Gli3 −/− cells situated dorsally (Fig. 4D) and medially ( Fig.   4G ) did not express Foxg1. Further rostrally (Fig. 4B) , medially located Gli3 −/− cells including those in the medial structure designated # did not express Foxg1 (Fig. 4H) . At rostral levels (Fig. 4C) , stripes of Gli3 −/ − cells in the medial dorsal telencephalic wall showed either no or only very faint staining for Foxg1 (Fig. 4F) . At caudal and central levels, Gli3 −/− cells located further laterally, in the neocortex, showed staining for Foxg1 at similar levels to their wild type neighbours (Fig.  4E) . Rostrally, while Gli3 −/− cells situated laterally in the neocortex were clearly positive for Foxg1, they were stained less strongly that their wild type neighbours (Fig. 4I ). In the ventral telencephalon, the intensity of staining for Foxg1 was similar between Gli3 +/+ and Gli3 Fig. 4K,L) . In summary, Gli3 −/− cells situated in the telencephalon closer to the dorsal midline and the boundary with the diencephalon do not express Foxg1 whereas Gli3 −/− cells situated further from the dorsal midline and the boundary with the diencephalon do express Foxg1.
Gsh2 expression
Expression of Gsh2 is normally restricted to proliferating cells of the ventral telencephalon and the ventral thalamus (Hsieh-Li et al., 1995) . In experimental chimeras (E12.5, n = 1; E14.5, n = 3; E15.5, n = 1), Gsh2 expression also encroached into parts of the dorsal telencephalon, where it was found in (i) many Gli3 Gsh2 ectopically (Figs. 5B,C,H) . Apart from at rostral levels, where ectopic expression was throughout the dorsal telencephalon (Fig. 5C ), Gsh2 was not expressed by Gli3 −/− cells located in the central part of the neocortex (Fig. 5B,I ). The abnormal Gli3 −/− region designated # did not express Gsh2 and nor did the eminentia thalami ( Fig. 5B ; (Hsieh-Li et al., 1995) . In summary, in Gli3 −/− ↔ Gli3 +/+ chimeras mutant cells in the eminentia thalami and the adjacent ectopic tissue designated #, which surround the diencephalic/telencephalic border, express neither Foxg1 nor Gsh2. Moving away from these tissues and further into the telencephalon, Gli3 −/− cells in segregated stripes and clusters in the medial dorsal telencephalon are Foxg1-negative, Gsh2-positive, a combination normally associated with ventral thalamic cells. Moving yet further into the dorsal telencephalon, Gli3 −/− cells in the central portion of the neocortex are Foxg1-positive, Gsh2-negative, a combination found in wild-type cells in this location. Approaching the rostral and lateral edges of the dorsal telencephalon, Gli3 −/− cells are Foxg1-positive, Gsh2-positive, a combination normally associated with ventral telencephalon.
Lim1/2 expression
The antibody used here labels differentiating diencephalic cells expressing Lim 1 and/or Lim2 (Lhx1 and/or 5) in the eminentia thalami, ventral thalamus and epithalamus (Sheng et al., 1997; Fotaki et al., 2006) . In experimental chimeras (E14.5, n = 3; E15.5, n = 2), additional expression of Lim1/2 was found in Gli3 −/− cells in the dorsal and medial telencephalic wall (marked ⁎ and med⁎ in Fig. 6A , shown in C and E) and the region designated # (Figs. 6B,D) . Lim1/2 expression was detected in neither Gli3 −/− nor Gli3 +/+ cells in most of the rest of the dorsal telencephalon (Figs. 6B,F; note that staining in panel B marked by arrowhead is an artefact), with the exception of the marginal zone, where it is known to be expressed in Cajal-Retzius cells (Fig. 6F ) (Yamazaki et al., 2004) . These findings indicate that Gli3
−/− cells in medial (but not lateral) parts of the dorsal telencephalon have adopted molecular identities associated with ventral thalamus and eminentia thalami. Data in Fig. 6F and Supplementary Fig. 1 indicate no major change in numbers of Reelin-positive Cajal-Retzius cells in Gli3 −/− neocortical regions in chimeras.
Tbr2 expression
Normally, Tbr2 is expressed in the dorsal telencephalon and the eminentia thalami, but is not expressed in the main body of either the ventral or dorsal thalamus (Brox et al., 2004; Englund et al., 2005; Quinn et al., 2007 ) (Quinn, unpublished observations). Tbr2 was telencephalic cells situated dorsomedially in the telencephalon (boxed area marked with ⁎ in Fig. 7A , shown in E; Fig. 9D ), consistent with these cells having an identity associated with thalamic cells (E12.5, n = 2; E14.5, n = 3; E15.5, n = 2). The region designated # showed a pattern of Tbr2 expression similar to than observed in the eminentia thalami (Fig. 7A,C) . Clusters of Gli3 −/− cells on the dorsal side of the PSPB were negative for Tbr2, which is not expressed by ventral telencephalic cells (Figs. 8C,D and 9B ).
Pax6 expression
Normally, Pax6 is expressed by cells in the dorsal telencephalon, the LGE, the eminentia thalami and the ventral thalamus (Walther and Gruss, 1991) . In Gli3 −/− ↔ Gli3 +/+ chimeras (E14.5, n = 3), Pax6 was expressed in cells of both genotypes in the dorsal telencephalon, including clusters of Gli3 −/− neocortical cells separated from the ventricular zone (e.g. arrowheads in Fig. 7B ), in the eminentia thalami and, in a similar pattern, in the region designated "#" (Figs. 7B,D) .
Nkx2.2 expression
The transcription factor Nkx2.2 is expressed in a highly restricted domain in the diencephalon, immediately anterior to the zona limitans intrathalamica (ZLI), which delimits the dorsal thalamus from the ventral thalamus ( Fig. 7F ; Kitamura et al., 1997; Price, 1993; Vue et al., 2007) . We did not observe expression of Nkx2.2 in any area of the telencephalon in Gli3 −/− ↔ Gli3 +/+ chimeras (E14.5, n =2) (Fig. 7F ),
suggesting that telencephalic Gli3 −/− cells do not acquire a diencephalic identity associated with ventral thalamic cells close to the ZLI.
Mash1 expression
Normally, Mash1 is expressed only on the ventral side of the PSPB (Casarosa et al., 1999) , but it was found extending into segregated clusters of Gli3 −/− cells on the dorsal side of the PSPB in Gli3 −/− ↔ Gli3 +/+ chimeras (E12.5, n = 1; E14.5, n = 2; E15.5, n = 1) (Figs. 8A,B) . At rostral levels in Gli3 −/− ↔ Gli3 +/+ chimeras there was ectopic expression of Mash1 in clusters of Gli3 −/− cells located dorsal to the PSPB (Fig. 8E) that did not express Pax6 (Fig. 8F) . These data are compatible with the hypothesis that Gli3 −/− cells in the lateral part of the dorsal telencephalon of experimental chimeras express transcription factors characteristic of ventral telencephalon.
Gad67 expression
The synthesis of GABA in the brain depends on the enzyme glutamate decarboxylase (GAD) and most GABAergic cells express the isoform Gad67. Most GABAergic interneurons in the cerebral cortex originate in ventral telencephalon and migrate into dorsal telencephalon from about E13 onwards. At first, most take up positions in the marginal, lower intermediate, subventricular and ventricular zones until postnatal ages, when they occupy the layers of the developing cortical plate (López-Bendito et al., 2004; Wonders and Anderson, 2006) . We compared the expression of Gad67 in Gli3 −/− and Gli3 +/+ cells in the dorsal telencephalon at E14.5; Gad67 expression was widespread in cells of both genotypes in the ventral telencephalon, as it is in wild type embryos at this age. Figs. 9A,C shows that clusters of Gli3 −/− cells situated in the cortical plate of the lateral (Fig. 9A) or medial ( Fig. 9C ) parts of the dorsal telencephalon expressed Gad67, whereas most of the surrounding wild type cortical plate cells did not. 
Dlx2 expression
We observed that clusters of Gli3 −/− cells situated in lateral and medial, but not central, parts of the chimeric dorsal telencephalon expressed the normally ventrally restricted transcription factor Dlx2 (E12.5, n = 1; E14.5, n = 2; E15.5, n = 1) (Bulfone et al., 1993 ). An example of a laterally located cluster of Gli3 −/− cells immunopositive for Dlx2 is shown in Fig. 9E .
Nkx2.1 expression
Nkx2.1 expression is normally restricted to the MGE and other ventral structures including the septum and preoptic area (Sussel et al., 1999) . This pattern of expression was maintained in chimeric forebrain: Fig. 9F shows expression of Nkx2.1 in Gli3 +/+ and Gli3 −/− (Tgpositive) cells in E14.5 chimeric ventral forebrain. Neither Gli3 −/− (Tgpositive) nor wild type cells in dorsal telencephalon were positive for Nkx2.1 (Fig. 9G ).
Discussion
Our main findings are: (1) Gli3 −/− cells are present in all components of the Gli3 −/− ↔ Gli3 +/+ chimeric forebrain in proportions that either equal or exceed the proportions found elsewhere in the embryo; (2) Gli3 −/− cells segregate from Gli3 +/+ cells forming many abnormal structures particularly in dorsal telencephalon and close to the boundary of telencephalon with diencephalon; (3) Gli3 −/− cells in the Gli3 −/− ↔ Gli3 +/+ telencephalon express abnormal sets of molecular markers that vary with location (summarized in Fig. 10A ).
Gli3
−/− cells are present in all forebrain tissue in chimeras
Many studies of Gli3 −/− mutants have indicated that developmental distortions of brain structures are caused by selective expansion of some tissues with reduction or absence of others (e.g. (Aoto et al., 2002; Blaess et al., 2008; Fotaki et al., 2006; Franz, 1994; Franz and Besecke, 1991; Grove et al., 1998; Hui and Joyner, 1993; Johnson, 1967; Theil et al., 1999; Tole et al., 2000; Zaki et al., 2005) . In the forebrain of Gli3 −/− embryos, the cerebral cortex is reduced in size with complete absence of dorsomedial telencephalon whereas the ventral telencephalon and diencephalon appear enlarged. Here we found that, in chimeras, Gli3 −/− cells contribute to all forebrain tissues, including those that are missing in Gli3 −/− mutants, in proportions that either exceed or are similar to the proportions contributing elsewhere in the embryo. The excessive contributions of mutant cells in some tissues might be explained if the absence of Gli3 from these cells enhances their ability to proliferate and/or survive. Our analysis of densities of dividing (pH3-expressing) cells in neocortical Gli3 −/− clusters suggests that proliferation of Gli3 −/− cells might be enhanced. Lack of Gli3 has been shown to enhance proliferation and also attenuate cell death elsewhere in the developing brain, in the midbrain and hindbrain (Blaess et al., 2008) . Previous in vitro work has shown that loss of Gli3 from embryonic telencephalic cells attenuates their death, although in this in vitro context proliferation was not enhanced (Zaki et al., 2005) . A complete understanding of proliferation and survival rates of Gli3 −/− cells in chimeras will require more study in the future. A major conclusion of our current work is that Gli3 is not required autonomously for cells to exist within the dorsomedial telencephalon, a region that does not exist in Gli3 −/− embryos. When chimeric analysis was used to examine the functions of another transcription factor, Pax6, in eye development, it was found that there was no contribution of Pax6 −/− cells to eye structures that are completely absent in Pax6
embryos, suggesting that Pax6 is required autonomously by cells of the missing structures for their generation and/or survival (Quinn et al., 2007) . In contrast to that situation, we conclude that Gli3 is not required to generate persistent populations of cells situated in the dorsomedial telencephalon; our results argue against the possibility that this tissue is absent in Gli3 −/− mutants because Gli3 −/− cells have an intrinsic inability to proliferate and survive in this location. Rather, our results suggest that Gli3 −/− cells in this location have an intrinsic inability to adopt a dorsomedial telencephalic identity. and Gli3 +/+ cells express very different sets of molecules regulating their cell-surface properties, whereas in ventral telencephalon and diencephalon differences are fewer. The properties of cells are controlled by the cocktails of transcription factors that they express and so we hypothesized that the extreme segregation of mutant and wild-type cells in dorsal telencephalon might arise from major differences in their identities, in terms of their expression of key transcription factors. Our analysis demonstrated that such differences exist. In parts of the dorsal telencephalon near to its boundary with the diencephalon, mutant cells expressed sets of transcription factors normally expressed by cells only on the diencephalic side of the boundary (Gsh2, Lim1/2, Dlx2, but not Foxg1; Fig. 10A ). Particularly striking was the generation of a structure designated # in Results that appeared, on the basis of its organization and pattern of gene expression, to be a duplication of the eminentia thalami at the telencephalic/diencephalic border (Lim1/2-positive, Tbr2-positive, Pax6-positive, but Gsh2-negative and Foxg1-negative: Fig. 10A ). In rostral and lateral parts of the dorsal telencephalon near to the ventral telencephalon, mutant cells also expressed sets of transcription factors normally expressed by cells only on the ventral side of the boundary (Gsh2, Mash1 and Dlx2; Fig. 10A ). Mutant cells in dorsal telencephalon expressed neither Nkx2.1 nor Nkx2.2; these markers are normally expressed by cells at a distance from the PSPB, in the MGE, and at a distance from the diencephalic/telencephalic border, immediately anterior to the ZLI (Price, 1993; Kitamura et al., 1997; Sussel et al., 1999; Vue et al., 2007) .These findings suggest that mutant cells in the dorsal telencephalon that are near to its boundaries express transcription factors normally restricted to cells in immediately adjacent territory. Furthermore, we observed that these dorsal telencephalic cells express abnormally high levels of Gad67, which is expressed by GABAergic interneurons. A number of studies have implicated molecules including Dlx2, Mash1 and Shh in the specification of GABAergic interneurons in the ventral telencephalon (reviewed by Wonders and Anderson, 2006) and the ectopic expression of Dlx2 and Mash1 in Gli3 −/− dorsal telencephalic cells is a possible explanation for the high levels of Gad67 expression by these cells. A model that might explain these findings is illustrated in Figs. 10B, C. It is known that diffusible morphogens such as bone morphogenetic factors (Bmps), fibroblast growth factors (Fgfs), Shh and Wnts released by cells within and around the developing neural plate pattern its major regions, regulating their molecular identities and subsequent development by causing the activation or repression of specific sets of transcription factors (for recent reviews see Aboitiz and Montiel, 2007; Hebert and Fishell, 2008; Takahashi and Liu, 2006) . Patterning also depends on the way in which cells in each region respond to the morphogens in their environment; this property, referred to as developmental competence, varies regionally. While diffusible morphogens that normally specify competent diencephalic and ventral telencephalic cells might cross the boundaries into dorsal telencephalon, dorsal telencephalic cells might be incompetent to respond to those morphogens. We suggest that an important action of Gli3 in dorsal telencephalon might be to prevent its cells responding to morphogens that pattern the diencephalon and ventral telencephalon (Fig. 10C ). The expression of Gli3 is compatible with this suggestion, being high in dorsal telencephalon, where posttranslational modification of its product generates high levels of a short repressor form (Gli3R), and declining through ventral telencephalon and diencephalon (Fotaki et al., 2006) . This model would explain why dorsal telencephalic cells lacking Gli3 adopt the identities of diencephalic and ventral telencephalic cells only if they are relatively close to the dorsal telencephalic boundaries. What the relevant morphogens might be is currently unclear; Wnts, Bmps and Fgfs are good candidates since they are expressed in these regions (Grove et al., 1998; Shimogori et al., 2004; Theil et al., 2002) and Gli3R can inhibit responses to Wnts by antagonizing active β-catenin (Ulloa and Briscoe, 2007) . Although Gli3 −/− dorsal telencephalic cells in a central part of the neocortex, i.e. distant from its lateral, rostral and medial boundaries, showed no alterations in their expression of the set of markers analysed here, they did show extreme segregation from their wildtype neighbours. The fact that they segregate indicates that there are molecular differences but further work is needed to discover their nature. The number of possible cell-surface molecular changes that might account for segregation of Gli3 −/− cells in the chimeras is large, and might include changes in the expression of members of the cell adhesion molecule, cadherin and integrin families. For example, Rcadherin is expressed in dorsal telencephalon with a boundary of expression at the PSPB (Stoykova et al., 1997) ; it is possible that loss of this adhesion molecule in Gli3 −/− cells in dorsal telencephalon might contribute to their segregation.
Conclusion
The aetiology of the numerous defects in the forebrain of Gli3 −/− mutants is likely to be complex, involving defects in the production and response to signalling molecules that pattern this region early in its development. Previous work concentrated on a consideration of the consequences of the known loss of signalling molecules as a result of the failure of formation of key dorsomedial telencephalic signalling centres (Fotaki et al., 2006; Kuschel et al., 2003; Rallu et al., 2002; Theil et al., 1999; Tole et al., 2000; Vyas et al., 2003) . Here, we have used chimeras to dissect the other side of the process, namely the cell autonomous actions of Gli3 in forebrain development. We suggest that a major cell autonomous action of Gli3 is to prevent dorsal telencephalic cells adopting identities inappropriate to this region. 
